Filing Details
- Accession Number:
- 0001161697-24-000505
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-12-11 17:00:29
- Reporting Period:
- 2024-12-09
- Accepted Time:
- 2024-12-11 17:00:29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1369568 | Catalyst Pharmaceuticals Inc. | CPRX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1402535 | Steve Miller | 355 Alhambra Circle, Suite 801 Coral Gables FL 33134 | Chief Op. & Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.001 Per Share | Acquisiton | 2024-12-09 | 11,872 | $0.00 | 686,996 | No | 4 | M | Direct | |
| Common Stock, Par Value $0.001 Per Share | Acquisiton | 2024-12-10 | 50,000 | $4.01 | 736,996 | No | 4 | M | Direct | |
| Common Stock, Par Value $0.001 Per Share | Disposition | 2024-12-10 | 50,000 | $21.93 | 686,996 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Disposition | 2024-12-09 | 11,872 | $0.00 | 11,872 | $0.00 |
| Common Stock | Options to purchase common stock | Disposition | 2024-12-10 | 50,000 | $0.00 | 50,000 | $4.01 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 1,837,176 | No | 4 | M | Direct | ||
| 1,787,176 | 2025-01-02 | No | 4 | M | Direct |
Footnotes
- Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
- Shares were sold on the open market for personal reasons and not as a result of any disagreement with the Company.
- Represents a weighted average price for the shares sold. Shares were sold in a range between $21.73 and $22.09 per share.
- Derivative securities vest in equal tranches, 1/3rd on December 8, 2024, 1/3rd on December 8, 2025 and 1/3rd on December 8, 2026.
- Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The first tranche of shares was delivered on December 9, 2024.
- Options vested in three annual tranches beginning on January 2, 2019.
Billionaire Hedge Funds
